- Home
- USEG vs BOLD Comparison
USEG vs BOLD Comparison
Compare USEG & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | USEG | BOLD |
|---|---|---|
| Founded | 1966 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.1M | 26.2M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | USEG | BOLD |
|---|---|---|
| Price | $1.06 | $1.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $3.50 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 285.1K | 178.9K |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,484,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $57.52 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.94 | $1.00 |
| 52 Week High | $6.40 | $3.54 |
Technical Indicators
Market Signals| Indicator | USEG | BOLD |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 44.40 |
| Support Level | $0.96 | $1.00 |
| Resistance Level | $1.05 | $1.18 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 92.30 | 58.24 |
Price Performance
Historical ComparisonAbout USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.